A Look At CME Group (CME) Valuation After Bitcoin Volatility Futures Launch News

CME Group (CME) has put cryptocurrency derivatives back in focus after announcing plans to launch Bitcoin Volatility futures on June 1, alongside reporting April average daily volume of 25.9 million contracts.

See our latest analysis for CME Group.

The stock has cooled off recently, with a 6.6% decline in the 1 month share price return and a 3% dip over 3 months. Even so, the year to date share price return is 6.9% and the 5 year total shareholder return sits at 66%, suggesting longer term holders have still seen meaningful gains.

If CME’s crypto volatility push has your attention, it may be a good moment to scan beyond a single stock and look at other crypto related opportunities via the Simply Wall St screener for 23 cryptocurrency and blockchain stocks

So with CME trading around US$288 and sitting roughly 6% below the average analyst price target, yet screening with a low value score of 2, is the recent pullback a genuine buying opportunity, or is future growth already reflected in the current price?

Most Popular Narrative: 6.4% Undervalued

With CME Group closing at $288.34 versus a narrative fair value of $308.20, the current pricing sits modestly below what this widely followed view assumes.

The ongoing global shift toward electronic trading, greater regulatory demands for transparency and standardized clearing, and a proven ability to grow non-transactional revenue (e.g., record market data revenue) position CME to capture a larger share of trading activity and support durable long-term earnings growth.

Read the complete narrative.

Curious what kind of revenue path and profit profile justify that fair value gap? The narrative leans on steady growth, strong margins, and a future earnings multiple that needs careful scrutiny.

The most popular narrative on CME Group applies a 7.87% discount rate, bakes in measured revenue and earnings expansion, and arrives at a fair value of $308.20, only slightly above the current analyst consensus target. Rather than signaling a dramatic mispricing, it frames today’s share price as requiring confidence in CME’s ability to sustain healthy margins and support a premium multiple over time, while still leaving a modest valuation cushion.

Result: Fair Value of $308.20 (UNDERVALUED)

Have a read of the narrative in full and understand what’s behind the forecasts.

However, that fair value gap relies on healthy derivatives activity and firm pricing power, while lower volatility or rising competition in DeFi style markets could pressure volumes and margins.

Find out about the key risks to this CME Group narrative.

Another Angle on Valuation

While the popular fair value narrative points to a modest undervaluation at around $308 per share, the P/E picture sends a mixed message. CME trades on 24.6x earnings versus a fair ratio of 15.4x, even though that 24.6x is below both the Capital Markets industry average of 42.7x and the peer average of 26.5x. That gap to the fair ratio suggests the market is already paying up for CME’s earnings quality, so the key question is whether you think the business is strong enough to keep justifying that premium, or potentially an even higher one.

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Seeing mixed signals so far and wondering how they balance out for you personally? Act while the data is fresh by weighing both sides through the 2 key rewards and 2 important warning signs.

Looking for more investment ideas?

If CME has sharpened your focus, do not stop here. Use the tools available to keep finding fresh ideas while this research is still top of mind.

This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com